Asthma risk factors

Elina Toskala, David W Kennedy, Elina Toskala, David W Kennedy

Abstract

Background: Bronchial asthma is one of the most common chronic diseases in childhood, with a current prevalence of 6% to 9%, but a prevalence that is increasing at an alarming rate. Asthma is a complex genetic disorder with strong environmental influence. It imposes a growing burden on our society in terms of morbidity, quality of life, and healthcare costs. Despite large-scale efforts, only a few asthma genes have been confirmed, suggesting that the genetic underpinning of asthma is highly complex.

Methods: A review of the literature was performed regarding atopic and nonatopic asthma risk factors, including environmental risk factors and genetic studies in adults and children.

Results: Several environmental risk factors have been identified to increase the risk of developing asthma such as exposure to air pollution and tobaccos smoke as well as occupational risk factors. In addition atopy, stress, and obesity all can increases the risk for asthma in genetically susceptible persons.

Conclusion: Asthma represents a dysfunctional interaction with our genes and the environment to which they are exposed, especially in fetal and early infant life. The increasing prevalence of asthma in all age groups indicate that our living environment and immunity are in imbalance with each other reacting with airway inflammation to the environmental exposures and often non-harmful proteins, such as allergens causing the current "asthma and allergy epidemic." Because of the close relationship between asthma and chronic rhinosinusitis, it is important that otolaryngologists have a good understanding of asthma, the etiologic factors associated with disease, and its evaluation and management.

Keywords: air pollution; allergens; asthma; atopy; environmental risk factors; epigenetics; genetic risk factors; hygiene hypothesis; microbes; risk factors.

© 2015 ARS-AAOA, LLC.

References

    1. American Lung Association . Asthma & Children Fact Sheet. September 2014. . Accessed May 14, 2015.
    1. American Lung Association. Asthma in Adults Fact Sheet . October 2012. . Accessed May 14, 2015.
    1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. 2007. . Accessed May 14, 2015.
    1. Centers for Disease Control and Prevention (CDC) . CDC Vital Signs. Asthma in the US. Growing every year. May 2011. . Accessed May 14, 2015.
    1. American Lung Association. Lung Disease Data: 2008. . Accessed May 14, 2015.
    1. Allen M, Heinzmann A, Noguchi E, et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet. 2003;35:258–263.
    1. Anderson SD. Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2 Suppl):25S‐30S.
    1. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47.
    1. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105:477–484.
    1. Cerveri I, Cazzoletti L, Corsico A, et al. The impact of cigarette smoking on asthma: a population‐based international cohort study. Int Arch Allergy Immunol. 2012;158:175–183.
    1. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross‐sectional world health survey. BMC Public Health. 2012;12:204.
    1. Flodin U, Jonsson P, Ziegler J, et al. An epidemiologic study of bronchial asthma and smoking. Epidemiology. 1995;6:503–505.
    1. Toren K, Hermansson BA. Incidence rate of adult‐onset asthma in relation to age, sex, atopy, and smoking: a Swedish population‐based study of 15813 adults. Int J Tuberc Lung Dis. 1999;3:192–197.
    1. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162:920–924.
    1. Chen Y, Dales R, Tang M, et al. Sex‐related interactive effect of smoking and household pets on asthma incidence. Eur Respir J. 2002;20:1162–1166.
    1. Piipari R, Jaakkola JJK, Jaakkola N, et al. Smoking and asthma in adults. Eur Respir J. 2004;24:734–739.
    1. Polosa R, Knoke JD, Russo C, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol. 2008;121:1428–1434.
    1. Strachan D, Cook D. Parental smoking and childhood asthma: longitudinal and case‐control studies. Thorax. 1998;53:204–212.
    1. U.S. Department of Health and Human Services . The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention; 2006.
    1. Burke H, Leonardi‐Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta‐analysis. Pediatrics. 2012;129:735–744.
    1. Accordini S, Janson C, Svanes C, et al. The role of smoking in allergy and asthma: lessons from the ECRHS. Curr Allergy Asthma Rep. 2012;12:185–191.
    1. Skorge T, Eagan T, Eide G, et al. The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. Am J Respir Crit Care Med. 2005;172:61–66.
    1. Centers for Disease Control and Prevention . National Center for Health Statistics. FastStats. Health Status and Risk Factors. Alcohol and Drug Use. Smoking. April 8, 2015. . Accessed May 14, 2015.
    1. Spears M, Cameron E, Chaudhuri R, et al. Challenges of treating asthma in people who smoke. Expert Rev Clin Immunol. 2010;6:257–268.
    1. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226–230.
    1. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175:783–790.
    1. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus nonsmokers with mild asthma. Thorax. 2005;60:282–287.
    1. Jung KH, Hsu S‐I, Moors KM, et al. Childhood exposure to fine particulate matter and black carbon and the development of new wheeze between ages 5 and 7 in an urban prospective cohort. Environ Int. 2012;45:44–50.
    1. Togias A, Fenton MJ, Gergen PJ, Rotrosen D, Fauci AS. Asthma in the inner city: the perspective of the National Institute of Allergy and Infectious Diseases. J Allergy Clin Immunol. 2010;125:540–544.
    1. Matsui EC. Environmental exposures and asthma morbidity in children living in urban neighbourhoods. Allergy. 2013:69:553–558.
    1. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home‐based environmental intervention among urban children with asthma. N Engl J Med. 2004;351:1068–1080.
    1. Eggleston PA, Butz A, Rand C, et al. Home environmental intervention in innercity asthma: a randomized controlled clinical trial. Ann Allergy Asthma Immunol. 2005;95:518–524.
    1. Keet CA, McCormack MC, Peng RD, Matsui EC. Age‐ and atopy‐dependent effects of vitamin D on wheeze and asthma. J Allergy Clin Immunol. 2011;128:414–416.
    1. Matsui EC, Matsui W. Higher serum folate levels are associated with a lower risk of atopy and wheeze. J Allergy Clin Immunol. 2009;123:1253–1259.
    1. Wu AC, Tantisira K, Li L, Fuhlbrigge AL, Weiss ST, Litonjua A. Effect of Vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med. 2012;186:508–513.
    1. Simons E, Curtin‐Brosnan J, Buckley T, Breysse P, Eggleston PA. Indoor environmental differences between inner city and suburban homes of children with asthma. J Urban Health. 2007;84:577–590.
    1. McCormack MC, Breysse PN, Matsui EC, et al. In‐home particle concentrations and childhood asthma morbidity. Environ Health Perspect. 2009;117:294–298.
    1. Sousa SI, Ferraz C, Alvim‐Ferraz MC, Vaz LG, Marques AJ, Martins FG. Indoor air pollution on nurseries and primary schools: impact on childhood asthma‐study protocol. BMC Public Health. 2012;12:435.
    1. Annesi‐Maesano I, Hulin M, Lavaud F, et al. Poor air quality in classrooms related to asthma and rhinitis in primary schoolchildren of the French 6 Cities Study. Thorax. 2012;67:682–688.
    1. Hulin M, Caillaud D, Annesi‐Maesano I. Indoor air pollution and childhood asthma: variations between urban and rural areas. Indoor Air. 2010;20:502–514.
    1. Miller RL, Peden DB. Environmental effects on immune responses in patients with atopy and asthma. J Allergy Clin Immunol. 2014:134:1001–1008.
    1. Lu KD, Breysse PN, Diette GB, et al. Being overweight increases susceptibility to indoor pollutants among urban children with asthma. J Allergy Clin Immunol. 2013;131:1017–1023.
    1. Weiss ST. Obesity: insight into the origins of asthma. Nat Immunol. 2005;6:537–539.
    1. Sutherland ER. Linking obesity and asthma. Ann N Y Acad Sci. 2014:1311;31–41.
    1. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181:315–323.
    1. Sutherland ER, Goleva E, King TS, et al. Cluster analysis of obesity and asthma phenotypes. PLoS One. 2012;7:e36631.
    1. Boulet L, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med. 2007;101:2240–2247.
    1. Peters‐Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27:495–503.
    1. Sutherland ER, Goleva E, Strand M, et al. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med. 2008;178:682–687.
    1. Malo JL, Vandenplas O. Definitions and classification of work‐related asthma. Immunol Allergy Clin North Am. 2011;31:645–662.
    1. Tan J, Bernstein JA. Occupational asthma: an overview. Curr Allergy Asthma Rep. 2014;431:1–7.
    1. Karvala K, Toskala E, Luukkonen R, Uitti J, Lappalainen S, Nordman H.. Prolonged exposure to damp and moldy workplaces and new‐onset asthma. Int Arch Occup Environ Health. 2011;84:713–721.
    1. Fuchs O, von Mutius E. Prenatal and childhood infections: implications for the development and treatment of childhood asthma. Lancet Resp Med. 2013:1:743–754.
    1. Kieninger E, Fuchs O, Latzin P, Frey U, Regamey N. Rhinovirus infections in infancy and early childhood. Eur Respir J. 2013;41:443–452.
    1. Xepapadaki P, Skevaki CL, Papadopoulos NG. The role of viral and bacterial infections on the development and exacerbations of asthma. In: Carlsen K‐H, Gerritsen J, eds. Paediatric Asthma. 2012:116–128.
    1. Sly PD, Boner AL, Bjorksten B, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet. 2008;372:1100–1006.
    1. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med. 2012;18:726–735.
    1. Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012;122:2741–2748.
    1. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545.
    1. James KM, Gebretsadik T, Escobar GJ, et al. Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. J Allergy Clin Immunol. 2013;132:227–229.
    1. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol. 2012;10:459–471.
    1. Bufford JD, Gern JE. The hygiene hypothesis revisited. Immunol Allergy Clin North Am. 2005;25:247–262.
    1. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Hygiene hypothesis of asthma: a murine asthma model with Mycoplasma pneumoniae infection. Chest. 2003;123(Suppl):390S.
    1. Prokopakis E, Vardouniotis A, Kawauchi H, et al. The pathophysiology of the hygiene hypothesis. Int J Pediatr Otolaryngol. 2013;77:1065–1077.
    1. Rosenberg SL, Miller GE, Brehm JM, Celedon JC. Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol. 2014;134:1009–1015.
    1. Ressler KJ, Mercer KB, Bradley B, et al. Post‐traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470:492–497.
    1. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis. 1990;142(6 Pt 1):1351–1358.
    1. Harris JR, Magnus P, Samuelsen SO, Tambs K. No evidence for effects of family environment on asthma. A retrospective study of Norwegian twins. Am J Respir Crit Care Med. 1997;156:43–49.
    1. Koppelman GH, Los H, Postma DS. Genetic and environment in asthma: the answer of twin studies. Eur Respir J. 1999;13:2–4.
    1. Nieminen MM, Kaprio J, Koskenvuo M. A population‐based study of bronchial asthma in adult twin pairs. Chest. 1991;100:70–75.
    1. Deichmann KA, Starke B, Schlenther S, et al. Linkage and association studies of atopy and the chromosome 11q13 region. J Med Genet. 1999;36:379–382.
    1. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006;7:95–100.
    1. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol. 2008;8:169–182.
    1. Zhang J, Pare PD, Sandford AJ. Recent advances in asthma genetics. Respir Res. 2008;9:4.
    1. Liggett SB. Genetics of beta 2‐adrenergic receptor variants in asthma. Clin Exp Allergy. 1995;25(Suppl 2):89–94; discussion 95–96.
    1. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2‐adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest. 1997;100:3184–3188.
    1. Potter PC, Van Wyk L, Martin M, Lentes KU, Dowdle EB. Genetic polymorphism of the beta‐2 adrenergic receptor in atopic and non‐atopic subjects. Clin Exp Allergy. 1993;23:874–877.
    1. Basehore MJ, Howard TD, Lange LA, et al. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol. 2004;114:80–87.
    1. Haller G, Torgerson DG, Ober C, Thompson EE. Sequencing the IL4 locus in African Americans implicates rare noncoding variants in asthma susceptibility. J Allergy Clin Immunol. 2009;124:1204–1209.e9.
    1. Munthe‐Kaas MC, Carlsen KH, Haland G, et al. T cell‐specific T‐box transcription factor haplotype is associated with allergic asthma in children. J Allergy Clin Immunol. 2008;121:51–56.
    1. Pykalainen M, Kinos R, Valkonen S, et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol. 2005;115:80–87.
    1. Randolph AG, Lange C, Silverman EK, et al. The IL12B gene is associated with asthma. Am J Hum Genet. 2004;75:709–715.
    1. Suttner K, Rosenstiel P, Depner M, et al. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol. 2009;123:1062–1068.e8.
    1. Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A. 2004;101:18099–18104.
    1. Zhou H, Hong X, Jiang S, Dong H, Xu X. Analyses of associations between three positionally cloned asthma candidate genes and asthma or asthma‐related phenotypes in a Chinese population. BMC Med Genet. 2009;10:123.
    1. Howard TD, Koppelman GH, Xu J, et al. Gene‐gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet. 2002;70:230–236.
    1. Kabesch M, Schedel M, Carr D, et al. IL‐4/IL‐13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol. 2006;117:269–274.
    1. Potaczek DP, Nishiyama C, Sanak M, Szczeklik A, Okumura K. Genetic variability of the high‐affinity IgE receptor α‐subunit (FcεRIα). Immunol Res. 2009;45:75–84.
    1. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL‐13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest. 2005;115:747–754.
    1. Wu X, Li Y, Chen Q, et al. Association and gene‐gene interactions of eight common single‐nucleotide polymorphisms with pediatric asthma in middle china. J Asthma. 2010;47:238–244.
    1. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008;322:881–888.
    1. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome‐wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356–369.
    1. Weiss ST, Raby BA, Rogers A. Asthma genetics and genomics 2009. Curr Opin Genet Dev. 2009;19:279–282.
    1. Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. J Allergy Clin Immunol. 2010;125(Suppl 2):S81‐S94.
    1. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome‐wide association studies for common human diseases. Nat Rev Genet. 2011;12:529–541.
    1. Relton CL, Davey Smith G. Two‐step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41:161–176.
    1. Begin P, Nadeau KC. Epigenetic regulation of asthma and allergic disease. Allergy Asthma Clin Immunol. 2014:10;1–12.
    1. Palmer LJ, Burton PR, Faux JA, James AL, Musk AW, Cookson WO. Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness. Am J Respir Crit Care Med. 2000;161:1836–1843.
    1. Cookson W, Moffatt M, Strachan DP: Genetic risks and childhood‐onset asthma. J Allergy Clin Immunol. 2011;128:266–270.
    1. Moffatt MF, Gut IG, Demenais F, et al.; GABRIEL Consortium. A large‐scale, consortium‐based genomewide association study of asthma. N Engl J Med. 2010;363:1211–1221.
    1. Passerini L, Santoni de Sio FR, Roncarolo MG, Bacchetta R. Forkhead box P3: the peacekeeper of the immune system. Int Rev Immunol. 2014;33:129–145.
    1. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non‐coding DNA elements in the Foxp3 gene in regulatory T‐cell fate. Nature. 2010;463:808–812.
    1. Kim HP, Leonard WJ. CREB/ATF‐dependent T cell receptor‐induced FoxP3 gene expression: a role for DNA methylation. J Exp Med. 2007;204:1543–1551.
    1. Polansky JK, Kretschmer K, Freyer J, et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol. 2008;38:1654–1663.
    1. Haiqi H, Yong Z, Yi L. Transcriptional regulation of Foxp3 in regulatory T cells. Immunobiology. 2011;216:678–685.
    1. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38:414–423.
    1. Zhang Y, Maksimovic J, Naselli G, et al. Genome‐wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood. 2013;122:2823–2836.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner